Expression of NANOG and NANOGP8 in a variety of undifferentiated and differentiated human cells

International Journal of Developmental Biology

Volumn 54, Issue 11-12, 2011, Pages 1743-1754

  Ambady, Sakthikumar ^a   Malcuit, Christopher ^a,b   Kashpur, Olga ^a   Kole, Denis ^a   Holmes, William F ^a   Hedblom, Emmett ^a   Page, Raymond L ^a,b,c   Dominko, Tanja ^a,b  

^a Worcester Polytechnic Institute   (United States)

^b WORCESTER POLYTECHNIC INSTITUTE   (United States)

^c Worcester Polytechnic Institute   (United States)

Author keywords

Differentiated cell; Expression; Human; NANOG; NANOGP8

Indexed keywords

TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR NANOG; TRANSCRIPTION FACTOR NANOGP8; UNCLASSIFIED DRUG;

ADULT; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CLONING; EMBRYO; EMBRYONAL CARCINOMA STEM CELL; EMBRYONIC STEM CELL; FIBROBLAST; GEL MOBILITY SHIFT ASSAY; GENE SEQUENCE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; IN VITRO STUDY; MESENCHYMAL STEM CELL; NEUROBLASTOMA CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PSEUDOGENE; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SEQUENCE ANALYSIS; SINGLE NUCLEOTIDE POLYMORPHISM; SMOOTH MUSCLE FIBER; UMBILICAL VEIN ENDOTHELIAL CELL; WESTERN BLOTTING;

AMINO ACID SEQUENCE; CELL DIFFERENTIATION; CONSENSUS SEQUENCE; ELECTROPHORETIC MOBILITY SHIFT ASSAY; EMBRYONIC STEM CELLS; FIBROBLASTS; GENE EXPRESSION; HELA CELLS; HOMEODOMAIN PROTEINS; HUMANS; MOLECULAR SEQUENCE DATA; MYOCYTES, SMOOTH MUSCLE; POLYMORPHISM, SINGLE NUCLEOTIDE; PSEUDOGENES; SEQUENCE ALIGNMENT;

EID: 80051480988     PISSN: 02146282     EISSN: None     Source Type: Journal    
DOI: 10.1387/ijdb.103192sa     Document Type: Article

References (49)

1. BARRAND, S. and COLLAS, P. (2009). Chromatin states of core pluripotency-associated genes in pluripotent, multipotent and differentiated cells. Biochem Biophys Res Commun 391: 762-767.
2. BOOTH, H. and HOLLAND, P. (2004). Eleven daughters of NANOG. Genomics 84: 229-238.
3. BOYER, L., LEE, T., COLE, M., JOHNSTONE, S., LEVINE, S., ZUCKER, J., GUENTHER, M., KUMAR, R., MURRAY, H., JENNER, R. et al. (2005). Core transcriptional regulatory circuitry in human embryonic stem cells. Cell 122: 947-956.
4. BYRNE, J., NGUYEN, H. and REIJO PERA, R. (2009). Enhanced generation of induced pluripotent stem cells from a subpopulation of human fibroblasts. PLoS One 4: e7118.
5. CHAMBERS, I., COLBY, D., ROBERTSON, M., NICHOLS, J., LEE, S., TWEEDIE, S. and SMITH, A. (2003). Functional expression cloning of Nanog, a pluripotency sustaining factor in embryonic stem cells. Cell 113: 643-655.
6. CHANG, D.F., TSAI, S.C., WANG, X.C., XIA, P., SENADHEERA, D. and LUTZKO, C. (2009). Molecular characterization of the human NANOG protein. Stem Cells 27: 812-821.
7. CHEN, J., SUN, M., KENT, W., HUANG, X., XIE, H., WANG, W., ZHOU, G., SHI, R. and ROWLEY, J. (2004). Over 20% of human transcripts might form sense-antisense pairs. Nucleic Acids Res 32: 4812-4820.
8. CLAMP, M., FRY, B., KAMAL, M., XIE, X., CUFF, J., LIN, M., KELLIS, M., LINDBLAD-TOH, K. and LANDER, E. (2007). Distinguishing protein-coding and noncoding genes in the human genome. Proc Natl Acad Sci USA 104: 19428-19433.
9. DO, H., LIM, H., KIM, J., SONG, H. and CHUNG, H. (2007). An intact homeobox domain is required for complete nuclear localization of human Nanog. Biochem Biophys Res Commun 353: 770-775.
10. ELLIMAN, S., WU, I. and KEMP, D. (2006). Adult tissue-specific expression of a Dppa3-derived retrogene represents a postnatal transcript of pluripotent cell origin. J Biol Chem 281: 16-19.
11. EZEH, U., TUREK, P., REIJO, R. and CLARK, A. (2005). Human embryonic stem cell genes OCT4, NANOG, STELLAR, and GDF3 are expressed in both seminoma and breast carcinoma. Cancer 104: 2255-2265.
12. HART, A., HARTLEY, L., IBRAHIM, M. and ROBB, L. (2004). Identification, cloning and expression analysis of the pluripotency promoting Nanog genes in mouse and human. Dev Dyn 230: 187-198.
13. HART, A., HARTLEY, L., PARKER, K., IBRAHIM, M., LOOIJENGA, L., PAUCHNIK, M., CHOW, C. and ROBB, L. (2005). The pluripotency homeobox gene NANOG is expressed in human germ cell tumors. Cancer 104: 2092-2098.
14. HATANO, S.Y.,TADA, M., KIMURA, H., YAMAGUCHI, S., KONO, T., NAKANO, T., SUEMORI, H., NAKATSUJI, N. and TADA, T. (2005). Pluripotential competence of cells associated with Nanog activity. Mech Dev 122: 67-79.
15. HYSLOP, L., STOJKOVIC, M., ARMSTRONG, L., WALTER, T., STOJKOVIC, P., PRZYBORSKI, S., HERBERT, M., MURDOCH, A., STRACHAN, T. and LAKO, M. (2005). Downregulation of NANOG induces differentiation of human embryonic stem cells to extraembryonic lineages. Stem Cells 23: 1035-1043.
16. JI, J., WERBOWETSKI-OGILVIE, T., ZHONG, B., HONG, S. and BHATIA, M. (2009). Pluripotent transcription factors possess distinct roles in normal versus transformed human stem cells. PLoS One 4: e8065.
17. KALMAR, T., LIM, C., HAYWARD, P., MUÑOZ-DESCALZO, S., NICHOLS, J., GARCIA-OJALVO, J. and MARTINEZ ARIAS, A. (2009). Regulated fluctuations in nanog expression mediate cell fate decisions in embryonic stem cells. PLoS Biol 7: e1000149.
18. KERR, C., HILL, C., BLUMENTHAL, P. and GEARHART, J. (2008). Expression of pluripotent stem cell markers in the human fetal testis. Stem Cells 26: 412-421.
19. KLOSE, R. and BIRD, A. (2006). Genomic DNA methylation: the mark and its mediators. Trends Biochem Sci 31: 89-97.
20. LIEDTKE, S., ENCZMANN, J., WACLAWCZYK, S., WERNET, P. and KOGLER, G. (2007). Oct4 and its pseudogenes confuse stem cell research. Cell Stem Cell 1: 364-366.
21. LIEDTKE, S., STEPHAN, M. and KÖGLER, G. (2008b). Oct4 expression revisited: potential pitfalls for data misinterpretation in stem cell research. Biol Chem 389: 845-850.
22. LISS, B. (2002). Improved quantitative real-time RT-PCR for expression profiling of individual cells. Nucleic Acids Res 30: e89.
23. MITSUI, K., TOKUZAWA, Y., ITOH, H., SEGAWA, K., MURAKAMI, M., TAKAHASHI, K., MARUYAMA, M., MAEDA, M. and YAMANAKA, S. (2003). The homeoprotein Nanog is required for maintenance of pluripotency in mouse epiblast and ES cells. Cell 113: 631-642.
24. MULLIN, N., YATES, A., ROWE, A., NIJMEIJER, B., COLBY, D., BARLOW, P., WALKINSHAW, M. and CHAMBERS, I. (2008). The pluripotency rheostat Nanog functions as a dimer. Biochem J 411: 227-231.
25. PAGE, R.L., AMBADY, S., HOLMES, W.F., VILNER, L., KOLE, D., KASHPUR, O., HUNTRESS, V., VOJTIC, I., WHITTON, H. and DOMINKO, T. (2009). Induction of stem cell gene expression in adult human fibroblasts without transgenes. Cloning Stem Cells 11: 417-426.
26. PAIN, D., CHIRN, G., STRASSEL, C. and KEMP, D. (2005). Multiple retropseudogenes from pluripotent cell-specific gene expression indicates a potential signature for novel gene identification. J Biol Chem 280: 6265-6268.
27. PAN, G. and PEI, D. (2003). Identification of two distinct transactivation domains in the pluripotency sustaining factor nanog. Cell Res 13: 499-502.
28. PANAGOPOULOS, I., MOLLER, E., COLLIN, A. and MERTENS, F. (2008). The POU5F1P1 pseudogene encodes a putative protein similar to POU5F1 isoform 1. Oncol Rep 20: 1029-1033.
29. PARK, I.H., ZHAO, R., WEST, J.A., YABUUCHI, A., HUO, H., INCE, T.A., LEROU, P.H., LENSCH, M.W. and DALEY, G.Q. (2008). Reprogramming of human somatic cells to pluripotency with defined factors. Nature 451: 141-146.
30. POLESSKAYA, A., CUVELLIER, S., NAGUIBNEVA, I., DUQUET, A., MOSS, E. and HAREL-BELLAN, A. (2007). Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev 21: 1125-1138.
31. QUE, J., LUO, X., SCHWARTZ, R. and HOGAN, B. (2009). Multiple roles for Sox2 in the developing and adult mouse trachea. Development 136: 1899-1907.
32. REN, J., GAO, X., JIN, C., ZHU, M., WANG, X., SHAW, A., WEN, L., YAO, X. and XUE, Y. (2009). Systematic study of protein sumoylation: Development of a site-specific predictor of SUMOsp 2.0. Proteomics 9: 3409-3412.
33. REUBINOFF, B., PERA, M., FONG, C., TROUNSON, A. and BONGSO, A. (2000). Embryonic stem cell lines from human blastocysts: somatic differentiation in vitro. Nat Biotechnol 18: 399-404.
34. RODRIGUEZ, R., VELKEY, J., LUTZKO, C., SEERKE, R., KOHN, D., O'SHEA, K. and FIRPO, M. (2007). Manipulation of OCT4 levels in human embryonic stem cells results in induction of differential cell types. Exp Biol Med (Maywood) 232: 1368-80.
35. SILVA, J., CHAMBERS, I., POLLARD, S. and SMITH, A. (2006). Nanog promotes transfer of pluripotency after cell fusion. Nature 441: 997-1001.
36. SILVA, J., NICHOLS, J., THEUNISSEN, T., GUO, G., VAN OOSTEN, A., BARRANDON, O., WRAY, J., YAMANAKA, S., CHAMBERS, I. and SMITH, A. (2009). Nanog is the gateway to the pluripotent ground state. Cell 138: 722-737.
37. SUO, G., HAN, J., WANG, X., ZHANG, J., ZHAO, Y. and DAI, J. (2005). Oct4 pseudogenes are transcribed in cancers. Biochem Biophys Res Commun 337: 1047-1051.
38. TAKAHASHI, K., TANABE, K., OHNUKI, M., NARITA, M., ICHISAKA, T., TOMODA, K. and YAMANAKA, S. (2007). Induction of pluripotent stem cells from adult human fibroblasts by defined factors. Cell 131: 861-872.
39. TORRENTS, D., SUYAMA, M., ZDOBNOV, E. and BORK, P. (2003). A genome-wide survey of human pseudogenes. Genome Res 13: 2559-2567.
40. TSURUZOE, S., ISHIHARA, K., UCHIMURA, Y., WATANABE, S., SEKITA, Y., AOTO, T., SAITOH, H., YUASA, Y., NIWA, H., KAWASUJI, M. et al. (2006). Inhibition of DNA binding of Sox2 by the SUMO conjugation. Biochem Biophys Res Commun 351: 920-926.
41. WANG, J., LEVASSEUR, D. and ORKIN, S. (2008). Requirement of Nanog dimerization for stem cell self-renewal and pluripotency. Proc Natl Acad Sci USA 105: 6326-6331.
42. WEI, F., SCHOLER, H.R. and ATCHISON, M.L. (2007). Sumoylation of Oct4 enhances its stability, DNA binding, and transactivation. J Biol Chem 282: 21551-21560.
43. YAMAGUCHI, S., KIMURA, H., TADA, M., NAKATSUJI, N. and TADA, T. (2005). Nanog expression in mouse germ cell development. Gene Expr Patterns 5: 639-646.
44. YATES, A. and CHAMBERS, I. (2005). The homeodomain protein Nanog and pluripotency in mouse embryonic stem cells. Biochem Soc Trans 33: 1518-1521.
45. YE, F., ZHOU, C., CHENG, Q., SHEN, J. and CHEN, H. (2008). Stem-cell-abundant proteins Nanog, Nucleostemin and Musashi1 are highly expressed in malignant cervical epithelial cells. BMC Cancer 8: 108.
46. YU, J., HU, K., SMUGA-OTTO, K., TIAN, S., STEWART, R., SLUKVIN, I. and THOMSON, J. (2009). Human induced pluripotent stem cells free of vector and transgene sequences. Science 324: 797-801.
47. YU, J., VODYANIK, M.A., SMUGA-OTTO, K., ANTOSIEWICZ-BOURGET, J., FRANE, J.L., TIAN, S., NIE, J., JONSDOTTIR, G.A., RUOTTI, V., STEWART, R. et al. (2007). Induced pluripotent stem cell lines derived from human somatic cells. Science 318: 1917-1920.
48. ZHANG, J., WANG, X., LI, M., HAN, J., CHEN, B., WANG, B. and DAI, J. (2006). NANOGP8 is a retrogene expressed in cancers. FEBS J 273: 1723-1730.
49. ZUK, P. (2009). The intracellular distribution of the ES cell totipotent markers OCT4 and Sox2 in adult stem cells differs dramatically according to commercial antibody used. J Cell Biochem 106: 867-877.